Ethyl 7-bromo-4-oxo-4H-quinolizine-3-carboxylate, 94% HPLC, 100mg

2,4-Dimethoxybenzoylacetonitrile, 95.0%, 500mg

3-(4-Bromophenyl)-1-(2-cyanoethyl)-1H-pyrazole-4-carbonitrile, 95.0%, 250mg

6-Bromo-N-methylquinolin-4-amine, 95.0%, 1g

trans-4-Aminocyclohexanemethanol hydrochloride, 97%, 5g

4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene>97.0%(GC)1g

(R)-1-BOC-2-(AMINOMETHYL)-4,4-DIFLUOROPYRROLIDINE, 95.0%, 500mg

5H-Spiro[furo[3,4-b]pyridine-7,4'-piperidine] dihydrochloride, 97%, 250mg

4-(2-Carboxy-1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid, 98%, 25mg

Diethyl Phenylmalonate>97.0%(GC)25mL

5-Chlorobenzoxazole, 95.0%, 25g

3-Amino-4-iodobenzonitrile, 95.0%, 250mg

Colonne capillaire GC ROTI®Cap-5, 25 m, 0,53 mm, 2,00 µm, 1 pièce(s)